Navigation Links
Filiform Double Pigtail Silicone Stent Sets

ProductsFiliform Double Pigtail Silicone Stent Sets
Company Cook Urological
Item Filiform Double Pigtail Silicone Stent Sets
Features 
  • The filiform stent assembly provides one pass placement.
Description Used for temporary internal drainage from the ureteropelvic junction to the bladder. The filiform stent assembly provides one pass placement. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not remain indwelling more than twelve (12) months.
Info Cook Urological
Customer Service: (800) 457-4448
Web site: http://www.cookurological.com/

Related medicine products :

1. Filiform Spiral Tip
2. Malleable Tip Filiforms
3. Storz Double Fixation Hook
4. Manson Double Ended Strabismus Hook
5. Castroviejo Double Ended Synechia Spatula
6. Castroviejo Double Ended Cyclodialysis Spatula
7. Nichamin Double Ended Nucleus Chopper-Spatula
8. Paton Double Ended Spatula
9. Ziegler Double Ended Lacrimal Dilator
10. Castroviejo Double Ended Lacrimal Dilator
11. Hasford Double Ended Lacrimal Dilator
The proven daily wear spherical soft contact lens.
Surevue brand contact lenses deliver exceptional overall performance in a contact lens since they're easy to use and offer great comfort.
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis.
The Naugle uses reflection mirrors to measure the position of the globe accurately, even after tumor removal or thyroid decompression. It delivers fast, reproducible results. The Naugle is easy to ha
Medicine Products:
(Date:5/16/2008)... HAE: TSX, MONTREAL...ation,(TSX:HAE), a specialty bio-therapeutics comp...rcialization, announced today that its Chairman of...li, will present at the,upcoming Rodman & Renshaw ..., May 20, 2008 in the Zephyr Room at Le Meridien B...
(Date:5/16/2008)... SAO PAULO, Brazil, May 16 /PRNewswire-FirstCall/ ...rs: TEMP3.SA; Bloomberg: TEMP3 BZ), a leading,prov... benefit plans and,specialized assistance services...r of 2008. The operating and financial information...d, is presented in Brazilian Reais and in,accordan...
(Date:5/15/2008)...PHILADELPHIA) Combining natural organic atoms wit...ute have developed a new type of enzyme inhibitor ...ys a key role in cancer development. , Based on...es the way for developing new ways to treat cancer...leads to uncontrolled tumor growth. , Details of...
(Date:5/15/2008)... HARBIN, China, May 15 /Xinhua-PRNewswire-FirstCal...tin Board: CYXI) ("China Yingxia" or "the,Company"...y engaged in the,development, manufacture and dist...plements, and personal care products in the People...inancial results for the first,quarter ended March...
Breaking Medicine News(10 mins):Health News:Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 2Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 4Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 5Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 7Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 8Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 9
...f proteins and performs the role of manufacture an...ene is none other than the cell nucleus//, which h...to be built. If a particular protein is to be manu...he nucleus. The nucleus consists of the RNA, a DNA...
...on delivery is known to offset birth trauma, fetal...evealed//. Researchers from the University of Tex...d that, one in 100 babies who have been delivered ... of injury during the process. The injuries range ...
...very that will help millions of tuberculosis patie...y say is faster//, cheaper and more accurate and a...the World Health Organization recommends the sputu...hich analyses the material expelled from the lungs...
...ed telemedicine researchers at University of Queen...alist medical care//, virtually shrinking ominous ... the blink of an eye. The robot named Eliza was c...h one of the world’s most renowned names in teleme...
Other Medicine News:Health News:The Living Cell – Manufacturing, Protecting and Thrivin 2Health News:Scientists Have Developed Faster, More Accurate TB Test 2Health News:Robots Help Bring Specialist Doctors To You In A Trice 2
(Date:5/15/2008)... France, May 15 /- Cerenis,Therapeuti...ompany,developing HDL-related compounds for the tr...today announced that it has completed a Phase I,cl...d product candidates.,CER-002 is a peroxisome prol...agonist in development for the treatment of cardio...
(Date:5/15/2008)... CenterWatch, a publishing and,information service...l,trials, finds that investigative sites are requi...) systems. More than 75% of respondents to a recen...trained on three or more,EDC systems. In addition,...eir EDC training had improved., State of the Clin...
(Date:5/15/2008)...wire-FirstCall/ -- Novavax, Inc. (Nasdaq:,NVAX) to...the Phase I/IIa,study of its pandemic influenza va...cts. Favorable interim results from the first phas...70 healthy adult volunteers, were,reported in Dece... vaccine,is well tolerated and immunogenic at the ...
(Date:5/15/2008)... Plan Positions Blue Cross Blue Shield of Mic...rt from HealthLeaders-Inter...ealthLeaders-InterStudy, the,leading provider of m...he,economy continues to stagnate in Michigan, Blue...uipped of all of its competitors to weather the,ec...
Breaking Medicine Technology:Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 1Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 3Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 4Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3446 5Phlo Reports Sharp Revenue Increase 3441 1Phlo Reports Sharp Revenue Increase 3441 2Cancer Cure Coalition Proposes Major Changes at the FDA 1404 1Cancer Cure Coalition Proposes Major Changes at the FDA 1404 2Cancer Cure Coalition Proposes Major Changes at the FDA 1404 3Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 1Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 2Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 3Lack of political will and the subordination of women are major barriers to tackling AIDS 12406 4